Assisted Reproductive Technology therapy Completed Phase 3 Trials for Progesterone (DB00396)

Also known as: Assisted Reproductive Technology / In Vitro Fertilization / Assisted fertilization / In Vitro Fertilization (IVF) / Artificial insemination by donor / Artificial insemination (partner) / Technology, Assisted Reproductive / Reproductive Technology, Assisted / Insemination, Artificial, Heterologous / DI - Donor insemination / Artificial insemination (donor) / In vitro fertilisation / Fertilization in Vitro / Assisted fertilisation / Artificial insemination by partner

IndicationStatusPhase
DBCOND0020337 (Assisted Reproductive Technology therapy)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00696800A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)Treatment
NCT00696878Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)Treatment
NCT00827983Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)Treatment
NCT00828191Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)Treatment